Beaudet AL, Sly XS, Valle D, eds. The metabolic basis of inherited disease, 6th ed. New York : McGraw Hill, 1989:2409 We examined an instrument-free test for C-reactive protein (CAP) in whole blood. The NycoCard CRP Whole Blood test uses a ceil-solubilizing dilution liquid, a membrane-bound antibody that binds CAP, and a gold-conjugated antibody for making visible the bound CRP. We obtained essentially identical dose-response curves in citrate-, hepann-, and EDTA-treated blood. CVs were 6.7-12.5% within series and 10.1-14.7% between series. The detection limit was 12 mg/L. lntralipidadded to blood increased measured CRP by 10-20%, whereas no change was seen with added bilirubin, added serum amyloid P component, or the presence of rheumatoid factor. In 234 patients' blood samples the results of the NycoCard Whole Blood test correlated well (r = 0.96) with those of a turbidimetric serum method. The test allows reliable measurement of CAP from a small volume of whole blood (25 L) without using expensive equipment; it should be useful for decentralized testing in hospital departments, emergency units, and primary health care centers. 
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ResuIts
The dose-response curves obtained with citrate-, heparin-, and EDTA-treated whole blood enriched with CR2 were essentially identical ( Figure 1 CR2 is located mainly in the plasma fraction of the blood, and our knowledge about changes in CR2 during disease is based on serum and plasma measurements. The NycoCard CR1' method allows CR1' concentration to be measured in whole blood. To avoid misinterpreting the results, NycoCard presents the values as serum values, assuming a hematocrit of 0.40. Therefore, the test will inevitably overestimate CR2 when the hematocrit is low and underestimate it when it is high. Even though a large fraction of our samples were from sick children in whom hematocrits are frequently abnormal, the results improved only marginally when we corrected for hematocrit.
We suggest that correction for hematocrit is necessary only for values >0.55 and even then only when CR2 is >10 mgfL. (2) and reportedly is less in groups of alcoholics than in nonalcoholic subjects (3) (4) (5) (6) (7) (8) 
